Announcement • Apr 21
Elbstein AG, Annual General Meeting, May 29, 2026 Elbstein AG, Annual General Meeting, May 29, 2026, at 10:00 W. Europe Standard Time. Buy Or Sell Opportunity • Mar 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 33% to €0.70. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Feb 05
Now 24% overvalued Over the last 90 days, the stock has fallen 8.3% to €1.10. The fair value is estimated to be €0.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Announcement • Aug 13
Elbstein AG, Annual General Meeting, Sep 19, 2025 Elbstein AG, Annual General Meeting, Sep 19, 2025, at 11:00 W. Europe Standard Time. Buy Or Sell Opportunity • Aug 12
Now 73% overvalued after recent price rise Over the last 90 days, the stock has risen 190% to €1.45. The fair value is estimated to be €0.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Buy Or Sell Opportunity • Jul 09
Now 44% overvalued after recent price rise Over the last 90 days, the stock has risen 138% to €1.19. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. New Risk • Jul 01
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (€13.5m market cap, or US$15.9m). New Risk • Mar 03
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (€110k revenue, or US$114k). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$15.6m). Announcement • Jul 29
Elbstein AG, Annual General Meeting, Sep 04, 2024 Elbstein AG, Annual General Meeting, Sep 04, 2024, at 11:00 W. Europe Standard Time. New Risk • Jul 01
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (42% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€21.0m market cap, or US$22.5m). New Risk • May 27
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 98% over the past year. Revenue is less than US$1m (€2.4k revenue, or US$2.6k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€15.0m market cap, or US$16.3m). Buy Or Sell Opportunity • May 22
Now 32% undervalued after recent price drop Over the last 90 days, the stock has fallen 2.0% to €0.50. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 02
Now 30% undervalued Over the last 90 days, the stock has risen 34% to €0.51. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making. Buying Opportunity • Jan 11
Now 30% undervalued after recent price drop Over the last 90 days, the stock is down 7.3%. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making. New Risk • Dec 08
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €7.50m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (43% average weekly change). Market cap is less than US$10m (€7.50m market cap, or US$8.06m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Buying Opportunity • Nov 18
Now 54% undervalued after recent price drop Over the last 90 days, the stock is down 25%. The fair value is estimated to be €0.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only. New Risk • Oct 12
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.30m (US$9.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€9.30m market cap, or US$9.81m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Buying Opportunity • Aug 01
Now 27% undervalued after recent price drop Over the last 90 days, the stock is down 65%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Buying Opportunity • Jul 12
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 62%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. New Risk • Jul 02
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€27.0m market cap, or US$29.5m). Buying Opportunity • Jun 15
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 62%. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 96% over the last year. Earnings per share has declined by 33%. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to €1.20, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to €1.30, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total loss to shareholders of 9.8% over the past three years. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to €1.54, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • Jan 18
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €1.15, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment deteriorated over the past week After last week's 19% share price decline to €1.21, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 17% over the past three years. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €1.50, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 4.1% over the past three years. Valuation Update With 7 Day Price Move • Sep 22
Investor sentiment deteriorated over the past week After last week's 20% share price decline to €1.60, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 10% over the past three years. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment deteriorated over the past week After last week's 23% share price decline to €1.55, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 6.9% over the past three years. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment improved over the past week After last week's 42% share price gain to €2.20, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 50% over the past three years. Valuation Update With 7 Day Price Move • May 23
Investor sentiment improved over the past week After last week's 17% share price gain to €2.06, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment deteriorated over the past week After last week's 28% share price decline to €2.10, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 66% over the past three years. Upcoming Dividend • Aug 20
Upcoming dividend of €0.05 per share Eligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improved over the past week After last week's 16% share price gain to €2.90, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 20x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years. Reported Earnings • Jun 29
Full year 2020 earnings released The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: €3.52m (up €3.11m from FY 2019). Net income: €2.83m (up 273% from FY 2019). Profit margin: 80% (down from 186% in FY 2019). The decrease in margin was primarily driven by higher revenue. Valuation Update With 7 Day Price Move • Mar 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €2.00, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 62.8x. This compares to an average P/E of 21x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 56%. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €2.20, the stock is trading at a trailing P/E ratio of 58x, down from the previous P/E ratio of 68.6x. This compares to an average P/E of 19x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 79%. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improved over the past week After last week's 19% share price gain to €2.20, the stock is trading at a trailing P/E ratio of 58x, up from the previous P/E ratio of 48.8x. This compares to an average P/E of 17x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 71%. Is New 90 Day High Low • Jan 15
New 90-day high: €2.04 The company is up 40% from its price of €1.46 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period. Valuation Update With 7 Day Price Move • Nov 12
Market bids up stock over the past week After last week's 33% share price gain to €2.00, the stock is trading at a trailing P/E ratio of 5.3x, up from the previous P/E ratio of 4x. This compares to an average P/E of 15x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 52%. Is New 90 Day High Low • Oct 02
New 90-day low: €14.50 The company is down 6.0% from its price of €15.50 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is down 10.0% over the same period.